Применение ботулинического токсина типа A в симптоматической терапии и медицинской реабилитации пациентов с рассеянным склерозом

Закрыть метаданные

Рекомендуем статьи по данной теме:

Дифференциальная диагностика воспалительного синдрома восстановления иммунитета и прогрессирующей мультифокальной энцефалопатии при отмене натализумаба. Журнал неврологии и психиатрии им. С.С. Корсакова. 2023;(3):116-121

Возможности оптимизации терапии у пациентов с фокальной эпилепсией, перенесших COVID-19. Журнал неврологии и психиатрии им. С.С. Корсакова. 2023;(3):130-136

Мультимодальная технология коррекции постинсультных двигательных нарушений. Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски. 2023;(3-2):58-67

Эффективность и безопасность 24 недель применения дивозилимаба среди пациентов с рассеянным склерозом в рамках рандомизированного двойного слепого плацебо-контролируемого клинического исследования BCD-132-2. Журнал неврологии и психиатрии им. С.С. Корсакова. 2023;(4):37-47

Особенности психоэмоциональной сферы и качества жизни у пациентов с вестибулярной мигренью. Журнал неврологии и психиатрии им. С.С. Корсакова. 2023;(4):48-52

Клинико-психологический профиль и качество жизни пациентов с постковидным синдромом. Журнал неврологии и психиатрии им. С.С. Корсакова. 2023;(4):53-58

Рассеянный склероз с эпизодом шизофреноподобного синдрома. Журнал неврологии и психиатрии им. С.С. Корсакова. 2023;(4):120-124

Нозогенные психосоматические расстройства у пациентов с кожными заболеваниями. Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски. 2023;(4-2):36-43

Использование ботулинического токсина типа А в эстетической коррекции лица: традиции, инновации и личный опыт. Пластическая хирургия и эстетическая медицина. 2023;(1):33-38

Валидация расширенной шкалы статуса инвалидизации (РСШИ) на русском языке для пациентов с рассеянным склерозом в Российской Федерации. Медицинские технологии. Оценка и выбор. 2023;(1):41-49

Представлен обзор современного состояния проблемы симптоматической терапии и медицинской реабилитации (МР) пациентов с рассеянным склерозом (РС). Поиск проводился в базах данных Medline, Web of Science, PubMed и Scopus. Приведены сведения о наиболее распространенных симптомах РС, среди которых наибольшее влияние на качество жизни пациентов, их функционирование и независимость в повседневной жизни оказывают сенсорные и моторные нарушения, дисфункция мочевого пузыря, боль. Рассмотрены клинические характеристики синдрома спастичности при РС и его связь с показателями качества жизни. Рассматриваются особенности применения ботулинотерапии (БТ) при РС. Показан высокий уровень эффективности применения БТ при лечении нейрогенной гиперактивности детрузора и нейрогенного мочевого пузыря (уровень убедительности рекомендации A) и спастичности (уровень убедительности рекомендации B). Симптоматическое лечение РС и МР с применением мультидисциплинарных программ способствуют снижению инвалидности, повышению качества жизни пациентов. При выборе симптоматического лечения и методов МР принято ориентироваться на потребности пациентов.

Ключевые слова:

рассеянный склероз

сенсорные нарушения

моторные нарушения

спастичность

дисфункция мочевого пузыря

симптоматическая терапия

медицинская реабилитация

ботулинотерапия

абоботулотоксин A

качество жизни

Авторы:

Костенко Е.В.

1. ГАУЗ «Московский научно-практический центр медицинской реабилитации, восстановительной и спортивной медицины» Департамента здравоохранения Москвы;
2. ФГАОУ ВО «Российский национальный исследовательский медицинский университет им. Н.И. Пирогова» Минздрава России

ORCID: 0000-0003-0902-348X

Дата поступления:

14.09.2023

Дата принятия в печать:

15.09.2023

Список литературы:

McAlpine D, Compston A. McAlpine’s multiple sclerosis. Churchill Livingstone. Elsevier Health Sciences. 2005.
Cotsapas C, Mitrovic M, Hafler D. Multiple sclerosis. Handb Clin Neurol. 2018;148:723-730. https://doi.org/10.1016/B978-0-444-64076-5.00046-6
Yamout BI, Alroughani R. Multiple Sclerosis. Semin Neurol. 2018;38(2):212-225. https://doi.org/10.1055/s-0038-1649502
Oh J, Vidal-Jordana A, Montalban X. Multiple sclerosis: clinical aspects. Curr Opin Neurol. 2018;31(6):752-759. https://doi.org/10.1097/WCO.0000000000000622
Ramagopalan SV, Maugeri NJ, Handunnetthi L, et al. Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D. PLoS Genet. 2009;5(2):e1000369. https://doi.org/10.1371/journal.pgen.1000369
Sospedra M, Martin R. Immunology of Multiple Sclerosis. Semin Neurol. 2016;36(2):115-127. https://doi.org/10.1055/s-0036-1579739
Fernández Ó, Costa-Frossard L, Martínez-Ginés M, et al. The Broad Concept of «Spasticity-Plus Syndrome» in Multiple Sclerosis: A Possible New Concept in the Management of Multiple Sclerosis Symptoms. Front Neurol. 2020;11:152. https://doi.org/10.3389/fneur.2020.00152
Zwibel HL. Contribution of impaired mobility and general symptoms to the burden of multiple sclerosis. Ad Ther. 2009;26(12):1043-1057. https://doi.org/10.1007/s12325-009-0082-x
Mross K, Jankowska M, Meller A, et al. Sensory Integration Disorders in Patients with Multiple Sclerosis. J Clin Med. 2022;11(17):5183. https://doi.org/10.3390/jcm11175183
Christogianni A, Bibb R, Davis SL, et al. Temperature sensitivity in multiple sclerosis: An overview of its impact on sensory and cognitive symptoms. Temperature (Austin). 2018;5(3):208-223. https://doi.org/10.1080/23328940.2018.1475831
Рассеянный склероз: избранные вопросы теории и практики. Под ред. Завалишина И.А. М. 2000.
Kararizou E, Lykomanos D, Kosma A, et al. Stereoanesthesia or astereognosia? Neurol Sci. 2009;30(5):409-411. https://doi.org/10.1007/s10072-009-0117-8
Numasawa Y, Irioka T, Mizusawa H. Pseudoradicular sensory loss caused by a cerebral demyelinative lesion. Intern Med. 2008;47(13):1287-1288. https://doi.org/10.2169/internalmedicine.47.1141
Osterberg A, Boivie J. Central pain in multiple sclerosis — sensory abnormalities. Eur J Pain. 2010;14(1):104-110. https://doi.org/10.1016/j.ejpain.2009.03.003
Rae-Grant AD, Eckert NJ, Bartz S, Reed JF. Sensory symptoms of multiple sclerosis: a hidden reservoir of morbidity. Mult Scler. 1999;5(3):179-183. https://doi.org/10.1177/135245859900500307
Thompson TL, Amedee R. Vertigo: a review of common peripheral and central vestibular disorders. Ochsner J. 2009;9(1):20-26.
Lane SJ, Mailloux Z, Schoen S, et al. Neural Foundations of Ayres Sensory Integration. Brain Sci. 2019;9(7):153. https://doi.org/10.3390/brainsci9070153
Miller LJ, Anzalone ME, Lane SJ, et al. Concept evolution in sensory integration: a proposed nosology for diagnosis. Am J Occup Ther. 2007;61(2):135-140. https://doi.org/10.5014/ajot.61.2.135
Larocca NG. Impact of walking impairment in multiple sclerosis: perspectives of patients and care partners. Patient. 2011;4(3):189-201. https://doi.org/10.2165/11591150-000000000-00000
Arpin DJ, Gehringer JE, Wilson TW, Kurz MJ. A reduced somatosensory gating response in individuals with multiple sclerosis is related to walking impairment. J Neurophysiol. 2017;118(4):2052-2058. https://doi.org/10.1152/jn.00260.2017
Krbot Skorić M, Crnošija L, Gabelić T, et al. Relationship Between Sensory Dysfunction and Walking Speed in Patients With Clinically Isolated Syndrome. J Clin Neurophysiol. 2018;35(1):65-70. https://doi.org/10.1097/WNP.0000000000000431
Conte A, Giannì C, Belvisi D, et al. Deep grey matter involvement and altered sensory gating in multiple sclerosis. Mult Scler. 2020;26(7):786-794. https://doi.org/10.1177/1352458519845287
Giannì C, Belvisi D, Conte A, et al. Altered sensorimotor integration in multiple sclerosis: A combined neurophysiological and functional MRI study. Clin Neurophysiol. 2021;132(9):2191-2198. https://doi.org/10.1016/j.clinph.2021.05.028
Sarrias-Arrabal E, Eichau S, Galvao-Carmona A, et al. Deficits in Early Sensory and Cognitive Processing Are Related to Phase and Nonphase EEG Activity in Multiple Sclerosis Patients. Brain Sci. 2021;11(5):629. https://doi.org/10.3390/brainsci11050629
Engel-Yeger B, DeLuca J, Hake P, Goverover Y. The role of sensory processing difficulties, cognitive impairment, and disease severity in predicting functional behavior among patients with multiple sclerosis. Disabil Rehabil. 2021;43(8):1129-1136. https://doi.org/10.1080/09638288.2019.1653998
Stern BZ, Strober LB, Goverover Y. Relationship between sensory processing patterns, trait anxiety, and health-related quality of life in multiple sclerosis. J Health Psychol. 2021;26(12):2106-2117. https://doi.org/10.1177/1359105319901316
Popa D, Spolidoro M, Proville RD, et al. Functional role of the cerebellum in gamma-band synchronization of the sensory and motor cortices. J Neurosci. 2013;33(15):6552-6556. https://doi.org/10.1523/JNEUROSCI.5521-12.2013
Wolpert DM, Diedrichsen J, Flanagan JR. Principles of sensorimotor learning. Nat Rev Neurosci. 2011;12(12):739-751. https://doi.org/10.1038/nrn3112
Bicks LK, Koike H, Akbarian S, Morishita H. Prefrontal Cortex and Social Cognition in Mouse and Man. Front Psychol. 2015;6:1805. https://doi.org/10.3389/fpsyg.2015.01805
Barrera K, Chu P, Abramowitz J, et al. Organization of myelin in the mouse somatosensory barrel cortex and the effects of sensory deprivation. Dev Neurobiol. 2013;73(4):297-314. https://doi.org/10.1002/dneu.22060
Бернштейн Н.А. Очерки по физиологии движений и физиологии активности. Лечебная физкультура и спортивная медицина. 2010;12:4-12.
Citaker S, Gunduz AG, Guclu MB, et al. Relationship between foot sensation and standing balance in patients with multiple sclerosis. Gait Posture. 2011;34(2):275-278. https://doi.org/10.1016/j.gaitpost.2011.05.015
Corporaal SH, Gensicke H, Kuhle J, et al. Balance control in multiple sclerosis: correlations of trunk sway during stance and gait tests with disease severity. Gait Posture. 2013;37(1):55-60. https://doi.org/10.1016/j.gaitpost.2012.05.025
Fling BW, Dutta GG, Schlueter H, et al. Associations between Proprioceptive Neural Pathway Structural Connectivity and Balance in People with Multiple Sclerosis. Front Hum Neurosci. 2014;8:814. https://doi.org/10.3389/fnhum.2014.00814
Jamali A, Sadeghi-Demneh E, Fereshtenajad N, Hillier S. Somatosensory impairment and its association with balance limitation in people with multiple sclerosis. Gait Posture. 2017;57:224-229. https://doi.org/10.1016/j.gaitpost.2017.06.020
Chung LH, Remelius JG, Van Emmerik RE, Kent-Braun JA. Leg power asymmetry and postural control in women with multiple sclerosis. Med Sci Sports Exerc. 2008;40(10):1717-1724. https://doi.org/10.1249/MSS.0b013e31817e32a3
Naito E, Nakashima T, Kito T, et al. Human limb-specific and non-limb-specific brain representations during kinesthetic illusory movements of the upper and lower extremities. Eur J Neurosci. 2007;25(11):3476-3487. https://doi.org/10.1111/j.1460-9568.2007.05587.x
Miehm JD, Buonaccorsi J, Lim J, et al. Sensorimotor function in progressive multiple sclerosis. Mult Scler J Exp Transl Clin. 2020;6(3):2055217320934835. https://doi.org/10.1177/2055217320934835
Remelius JG, Jones SL, House JD, et al. Gait impairments in persons with multiple sclerosis across preferred and fixed walking speeds. Arch Phys Med Rehabil. 2012;93(9):1637-1642. https://doi.org/10.1016/j.apmr.2012.02.019
Truini A, Galeotti F, Cruccu G. Treating pain in multiple sclerosis. Expert Opin Pharmacother. 2011;12(15):2355-2368. https://doi.org/10.1517/14656566.2011.607162
O’Connor AB, Schwid SR, Herrmann DN, et al. Pain associated with multiple sclerosis: systematic review and proposed classification. Pain. 2008;137(1):96-111. https://doi.org/10.1016/j.pain.2007.08.024
Solaro C, Uccelli MM. Management of pain in multiple sclerosis: a pharmacological approach. Nat Rev Neurol. 2011;7(9):519-527. https://doi.org/10.1038/nrneurol.2011.120
Svendsen KB, Jensen TS, Hansen HJ, Bach FW. Sensory function and quality of life in patients with multiple sclerosis and pain. Pain. 2005;114(3):473-481. https://doi.org/10.1016/j.pain.2005.01.015
Scherder RJ, Kant N, Wolf ET, et al. Sensory Function and Chronic Pain in Multiple Sclerosis. Pain Res Manag. 2018;2018:1924174. https://doi.org/10.1155/2018/1924174
Ghosh R, Roy D, Dubey S, et al. Movement Disorders in Multiple Sclerosis: An Update. Tremor Other Hyperkinet Mov (N Y). 2022;12:14. https://doi.org/10.5334/tohm.671
Zecca C, Manconi M, Fulda S, Gobbi C. Restless legs syndrome in multiple sclerosis. CNS Neurol Disord Drug Targets. 2012;11(8):1061-1069. https://doi.org/10.2174/1871527311211080017
Giannaki CD, Aristotelous P, Stefanakis M, et al. Restless legs syndrome in Multiple Sclerosis patients: a contributing factor for fatigue, impaired functional capacity, and diminished health-related quality of life. Neurol Res. 2018;40(7):586-592. https://doi.org/10.1080/01616412.2018.1454719
Sieminski M, Losy J, Partinen M. Restless legs syndrome in multiple sclerosis. Sleep Med Rev. 2015;22:15-22. https://doi.org/10.1016/j.smrv.2014.10.002
Ozdogar AT, Kalron A. Restless legs syndrome in people with multiple sclerosis: An updated systematic review and meta-analyses. Mult Scler Relat Disord. 2021;56:103275. https://doi.org/10.1016/j.msard.2021.103275
Monschein T, Schestak C, Schillerwein-Kral C, et al. Restless Legs Syndrome in Multiple Sclerosis: Risk factors and effect on sleep quality — a case-control study. Mult Scler Relat Disord. 2021;51:102916. https://doi.org/10.1016/j.msard.2021.102916
Cederberg KLJ, Jeng B, Sasaki JE, et al. Restless legs syndrome and health-related quality of life in adults with multiple sclerosis. J Sleep Res. 2020;29(3):e12880. https://doi.org/10.1111/jsr.12880
Makhoul K, Ahdab R, Riachi N, et al. Tremor in Multiple Sclerosis-An Overview and Future Perspectives. Brain Sci. 2020;10(10):722. https://doi.org/10.3390/brainsci10100722
Koch M, Mostert J, Heersema D, De Keyser J. Tremor in multiple sclerosis. J Neurol. 2007;254(2):133-145. https://doi.org/10.1007/s00415-006-0296-7
Ashizawa T, Xia G. Ataxia. Continuum (Minneap Minn). 2016;22(4 Movement Disorders):1208-1226. https://doi.org/10.1212/CON.0000000000000362
Mills RJ, Yap L, Young CA. Treatment for ataxia in multiple sclerosis. Cochrane Database Syst Rev. 2007;(1):CD005029. https://doi.org/10.1002/14651858.CD005029.pub2
Skillrud DM, Goldstein NP. Paroxysmal limb hemiataxia with crossed facial paresthesias in multiple sclerosis. JAMA. 1983;250(20):2843-2844.
Berger JR, Sheremata WA, Melamed E. Paroxysmal dystonia as the initial manifestation of multiple sclerosis. Arch Neurol. 1984;41(7):747-750. https://doi.org/10.1001/archneur.1984.04050180069020
Machado C, Amorim JM, Rodrigues M, et al. Paroxysmal dystonia as a manifestation of multiple sclerosis. Neurologist. 2015;19(5):132-134. https://doi.org/10.1097/NRL.0000000000000025
Yilmaz S, Serdaroglu G, Gokben S, Tekgul H. Paroxysmal dystonia as a rare initial manifestation of multiple sclerosis. J Child Neurol. 2011;26(12):1564-1566. https://doi.org/10.1177/0883073811410882
Fontoura P, Vale J, Guimarães J. Symptomatic paroxysmal hemidystonia due to a demyelinating subthalamic lesion. Eur J Neurol. 2000;7(5):559-562. https://doi.org/10.1046/j.1468-1331.2000.t01-1-00110.x
Mehanna R, Jankovic J. Movement disorders in multiple sclerosis and other demyelinating diseases. J Neurol Sci. 2013;328(1-2):1-8. https://doi.org/10.1016/j.jns.2013.02.007
Sankhla CS, Patil KB. Paroxysmal tonic spasms as an initial manifestation of neuromyelitis optica. Neurol India. 2017;65(3):631-632. https://doi.org/10.4103/neuroindia.NI_865_16
Kim JS, Guak TH, Ahn JY, et al. Writer’s cramp as a manifestation of cervical demyelinating lesions. Eur Neurol. 2007;58:54-56. https://doi.org/10.1159/000102169
Restivo DA, Solaro C, Maimone D, et al. Pharyngeal painful tonic spasms: paroxysmal painful swallowing. Ann Intern Med. 2011;155(9):649-650. https://doi.org/10.7326/0003-4819-155-9-201111010-00024
Cavallieri F, Godeiro C, Lino JC Jr, et al. Cervical dystonia in a case of longstanding secondary progressive multiple sclerosis. Rev Neurol (Paris). 2019;175(4):269-271. https://doi.org/10.1016/j.neurol.2018.05.005
Palasí A, Martínez-Sánchez N, Bau L, et al. Unilateral eyelid myokymia as a form of presentation of multiple sclerosis. Neurologia. 2013;28(3):187-189. https://doi.org/10.1016/j.nrl.2011.09.010
Dupeyron A, et al. Hemicontracture and facial myokimia as the first manifestation of multiple sclerosis. Revue Neurologique. 2001;157(3):315-317.
Salavisa M, Serrazina F, Pires P, et al. Teaching Video NeuroImages: Infratentorial Multiple Sclerosis Relapse Presenting as Continuous Hemifacial Myokymia. Neurology. 2021;97(1):111-112. https://doi.org/10.1212/WNL.0000000000012052
Marin Collazo IV, Tobin WO. Facial Myokymia and Hemifacial Spasm in Multiple Sclerosis: A Descriptive Study on Clinical Features and Treatment Outcomes. Neurologist. 2018;23(1):1-6. https://doi.org/10.1097/NRL.0000000000000163
Sedano MJ, Trejo JM, Macarrón JL, et al. Continuous facial myokymia in multiple sclerosis: treatment with botulinum toxin. Eur Neurol. 2000;3:137-140. https://doi.org/10.1159/000008152
Abboud H, Yu XX, Knusel K, et al. Movement disorders in early MS and related diseases: A prospective observational study. Neurol Clin Pract. 2019;9(1):24-31. https://doi.org/10.1212/CPJ.0000000000000560
Telischi FF, Grobman LR, Sheremata WA, et al. Hemifacial spasm occurrence in multiple sclerosis. Arch Otolaryngol Head Neck Surg. 1991;117(5):554-556. https://doi.org/10.1001/archotol.1991.01870170100022
Freiha J, Riachi N, Chalah MA, et al. Paroxysmal Symptoms in Multiple Sclerosis-A Review of the Literature. J Clin Med. 2020;9(10):3100. https://doi.org/10.3390/jcm9103100
Nociti V, Fasano A, Bentivoglio AR, et al. Tourettism in multiple sclerosis: a case report. J Neurol Sci. 2009;287(1-2):288-290. https://doi.org/10.1016/j.jns.2009.07.009
Deutsch SI, Rosse RB, Connor JM, et al. Current status of cannabis treatment of multiple sclerosis with an illustrative case presentation of a patient with MS, complex vocal tics, paroxysmal dystonia, and marijuana dependence treated with dronabinol. CNS Spectr. 2008;13(5):393-403. https://doi.org/10.1017/S1092852900016564
Lana-Peixoto MA, Teixeira AL. Brazilian Committee for Treatment and Research in Multiple Sclerosis. Simple phonic tic in multiple sclerosis. Mult Scler. 2002;8(6):510-511. https://doi.org/10.1191/1352458502ms829oa
Rizzo MA, Hadjimichael OC, Preiningerova J, Vollmer TL. Prevalence and treatment of spasticity reported by multiple sclerosis patients. Mult Scler. 2004;10(5):589-595. https://doi.org/10.1191/1352458504ms1085oa
Flachenecker P, Henze T, Zettl UK. Spasticity in patients with multiple sclerosis — clinical characteristics, treatment and quality of life. Acta Neurol Scand. 2014;129(3):154-162. https://doi.org/10.1111/ane.12202
Ишемический инсульт и транзиторная ишемическая атака у взрослых. Клинические рекомендации. М.: Министерство здравоохранения Российской Федерации; 2021.
Zettl UK, Henze T, Essner U, Flachenecker P. Burden of disease in multiple sclerosis patients with spasticity in Germany: mobility improvement study (Move I). Eur J Health Econ. 2014;15(9):953-966. https://doi.org/10.1007/s10198-013-0537-5
Svensson J, Borg S, Nilsson P. Costs and quality of life in multiple sclerosis patients with spasticity. Acta Neurol Scand. 2014;129(1):13-20. https://doi.org/10.1111/ane.12139
Kister I, Bacon TE, Chamot E, et al. Natural history of multiple sclerosis symptoms. Int J MS Care. 2013;15(3):146-158. https://doi.org/10.7224/1537-2073.2012-053
Гусев Е.И., Костенко Е.В., Бойко А.Н. Спастичность: клиника, диагностика и комплексная реабилитация с применением ботулинотерапии. 3-е издание, переработанное и дополненное. М.: ГЭОТАР-Медиа; 2023. https://doi.org/10.33029/9704-7652-9-SPA-2023-1-312
Heesen C, Böhm J, Reich C, et al. Patient perception of bodily functions in multiple sclerosis: gait and visual function are the most valuable. Mult Scler. 2008;14(7):988-991. https://doi.org/10.1177/1352458508088916
Simmons RD, Tribe KL, McDonald EA. Living with multiple sclerosis: longitudinal changes in employment and the importance of symptom management. J Neurol. 2010;257:926-936. https://doi.org/10.1007/s00415-009-5441-7
Heller M, Taylor D. Greater Expectations: The Future Hopes of People With Multiple Sclerosis. 2017. https://pdfs.semanticscholar.org/866a/959d88a224883f7e9dd5ddbec31017f36bac.pdf
Khan F, Amatya B. Rehabilitation in Multiple Sclerosis: A Systematic Review of Systematic Reviews. Arch Phys Med Rehabil. 2017;98(2):353-367. https://doi.org/10.1016/j.apmr.2016.04.016
Khan F, Turner-Stokes L, Ng L, et al. Multidisciplinary rehabilitation for adults with multiple sclerosis. Cochrane Database of Syst Rev. 2007;2(5):CD006036.pub2. https://doi.org/10.1002/14651858.cd006036.pub2
Amatya B, Khan F, Galea M. Rehabilitation for people with multiple sclerosis. Cochrane Database Syst Rev. 2019;1(1):CD012732. https://doi.org/10.1002/14651858.CD012732.pub2
Haselkorn JK, Hughes C, Rae-Grant A, et al. Summary of comprehensive systematic review: Rehabilitation in multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology. 2015;85(21):1896-1903. https://doi.org/10.1212/WNL.0000000000002146
Переседова А.В., Черникова Л.А., Завалишин И.А. Физическая реабилитация при рассеянном склерозе: общие принципы и современные высокотехнологичные методы. Вестник Российской академии медицинских наук. 2013;68(10):14-21.
Mehnert U. The management of urine storage dysfunction in the neurological patient. Comprehensive Clinical Medicine. 2019;1(2):160-182.
Blok B, Groen J, Pannek J, et al. Summary of European Association of Urology (EAU) Guidelines on Neuro-Urology. Eur Urol. 2016;69(2):324-333. https://doi.org/10.1016/j.eururo.2015.07.071
Нейрогенная дисфункция нижних мочевыводящих путей. Клинические рекомендации. М.: Министерство здравоохранения Российской Федерации; 2021.
Инструкция по применению, Диспорт 300 ЕД, РУ №ЛП-001486, Инструкция по применению, Диспорт 500 ЕД, РУ №ПN011520/01.
Kennelly M, Cruz F, Herschorn S, et al. Efficacy and Safety of AbobotulinumtoxinA in Patients with Neurogenic Detrusor Overactivity Incontinence Performing Regular Clean Intermittent Catheterization: Pooled Results from Two Phase 3 Randomized Studies (CONTENT1 and CONTENT2). Eur Urol. 2022;82(2):223-232. https://doi.org/10.1016/j.eururo.2022.03.010
Dressler D, Bhidayasiri R, Bohlega S, et al. Botulinum toxin therapy for treatment of spasticity in multiple sclerosis: review and recommendations of the IAB-Interdisciplinary Working Group for Movement Disorders task force. J Neurol. 2017;264(1):112-120. https://doi.org/10.1007/s00415-016-8304-z
Гусев Е.И., Завалишин И.А., Бойко А.Н. Рассеянный склероз. М.: Реал Тайм; 2011.
Малик О., Донелли Э., Барнетт М. Рассеянный склероз. Краткий справочник. Пер. с англ. Под ред. Бойко А.Н. М.: Практическая медицина; 2015.
Хатькова С.Е. Очаговое повреждение головного мозга у взрослых: синдром спастичности. Клинические рекомендации. М.: МЕДпресс-Информ; 2017.
Gracies JM, Brashear A, Jech R, et al. Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial. Lancet Neurol. 2015;14(10):992-1001. https://doi.org/10.1016/S1474-4422(15)00216-1
Simpson DM, Hallett M, Ashman EJ, et al. Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache: Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2016;86(19):1818-1826. https://doi.org/10.1212/WNL.0000000000002560
Rosales RL, Efendy F, Teleg ES, et al. Botulinum toxin as early intervention for spasticity after stroke or non-progressive brain lesion: A meta-analysis. J Neurol Sci. 2016;371:6-14. https://doi.org/10.1016/j.jns.2016.10.005
Мокиенко О.А., Супонева Н.А. Инсульт у взрослых: центральный парез верхней конечности. Клинические рекомендации. М.: МЕДпресс-Информ; 2018.
Хатькова С.Е., Орлова О.Р., Боцина А.Ю. и др. Основные принципы ведения пациентов с нарушением мышечного тонуса после очагового повреждения головного мозга. Consilium Medicum. 2016;18(2-1):25-33.
Хатькова С.Е., Акулов М.А., Орлова О.Р. и др. Ботулинотерапия в лечении спастичности нижней конечности. Нервно-мышечные болезни. 2017;7(3):21026. https://doi.org/10.17650/2222-8721-2017-7-3-21-35
Simpson DM, Gracies JM, Graham HK, et al. Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2008;70(19):1691-1698. https://doi.org/10.1212/01.wnl.0000311391.00944.c4
Hyman N, Barnes M, Bhakta B, et al. Botulinum toxin (Dysport) treatment of hip adductor spasticity in multiple sclerosis: a prospective, randomised, double blind, placebo controlled, dose ranging study. J Neurol Neurosurg Psychiatry. 2000;68(6):707-712. https://doi.org/10.1136/jnnp.68.6.707
Safarpour Y, Mousavi T, Jabbari B. Botulinum Toxin Treatment in Multiple Sclerosis-a Review. Curr Treat Options Neurol. 2017;19(10):33-38. https://doi.org/10.1007/s11940-017-0470-5
Костенко Е.В., Бойко А.Н. Коррекция спастического повышения мышечного тонуса при рассеянном склерозе с использованием ботулинотерапии. Журнал неврологии и психиатрии им. С.С. Корсакова. 2018;118(7):89-93. https://doi.org/10.17116/jnevro20181187189
Fu X, Wang Y, Wang C, et al. A mixed treatment comparison on efficacy and safety of treatments for spasticity caused by multiple sclerosis: a systematic review and network meta-analysis. Clin Rehabil. 2018;32(6):713-721. https://doi.org/10.1177/0269215517745348
Gracies JM, O’Dell M, Vecchio M, et al. Effects of repeated abobotulinumtoxinA injections in upper limb spasticity. Muscle Nerve. 2018;57(2):245-254. https://doi.org/10.1002/mus.25721
Brashear A, Gordon MF, Elovic E, et al. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke. N Engl J Med. 2002;347(6):395-400. https://doi.org/10.1056/NEJMoa011892
Moccia M, Frau J, Carotenuto A, et al. Botulinum toxin for the management of spasticity in multiple sclerosis: the Italian botulinum toxin network study. Neurol Sci. 2020;41(10):2781-2792. https://doi.org/10.1007/s10072-020-04392-8
Bensmail D, Karam P, Forestier A, et al. Trends in Botulinum Toxin Use among Patients with Multiple Sclerosis: A Population-Based Study. Toxins (Basel). 2023;15(4):280. https://doi.org/10.3390/toxins15040280
Winstein CJ, Stein J, Arena R, et al. Guidelines for Adult Stroke Rehabilitation and Recovery: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association [published correction appears in Stroke. Stroke. 2017;48(2):78-83. https://doi.org/10.1161/STR.0000000000000098
Gracies JM. The Concept of Guided Self-Rehabilitation Contracts in the Treatment of Deforming Spastic Paresis. Physikalische Medizin, Rehabilitationsmedizin, Kurortmedizin. 2015;25(3):26-30.
Brown TR, Kraft GH. Exercise and rehabilitation for individuals with multiple sclerosis. Phys Med Rehabil Clin N Am. 2005;16(2):513-555. https://doi.org/10.1016/j.pmr.2005.01.005

Закрыть метаданные